OSCAR POLICY GROUP, LLC

Incentivize domestic manufacturing through grants and tax credits to reduce foreign reliance. Strengthen FDA oversight on imports while expediting reviews for qualified U.S. producers. Prioritize patient safety by favoring traceable, U.S.-made APIs in procurement and reimbursement policies. Standardize quality by collaborating with industry on robust testing protocols for potency and purity. Streamline approvals for domestic manufacturers to resolve supply shortages and quality gaps.